Want to see QTEX full AI Analyst Report?
QTEX Stock Chart & Stats
$0.96
-$0.05(-4.95%)
At close: 4:00 PM EST
$0.96
-$0.05(-4.95%)
Day’s Range― - ―
52-Week Range$0.28 - $3.85
Previous CloseN/A
VolumeN/A
Average Volume (3M)330.47K
Market Cap
$70.16M
Enterprise Value$4.62M
Total Cash (Recent Filing)$2.13M
Total Debt (Recent Filing)$640.00K
Price to Earnings (P/E)―
Beta3.38
Next Earnings
Aug 06, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding43,579,260
10 Day Avg. Volume227,613
30 Day Avg. Volume330,466
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)11.48
Price to Sales (P/S)92.25
P/FCF Ratio-2.68
Enterprise Value/Market Cap0.07
Enterprise Value/Revenue15.99
Enterprise Value/Gross Profit2.31K
Enterprise Value/Ebitda-0.65
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.11
Revenue Forecast (FY)$48.00M
Bulls Say, Bears Say
Bulls Say
Provisional Patent - Cryogenic InterconnectThe provisional patent for a controlled‑conductivity cryogenic microwave interconnect targets a core hardware bottleneck in superconducting quantum systems. IP protection plus early collaborator technical evaluations create a durable differentiation that can secure customer engagements and licensing opportunities over the medium term.
Single-build AME Cryogenic Chip CarrierExtending its AME platform into monolithic cryogenic chip carriers broadens product scope into the processor‑interface layer. Integrated carriers reduce connector failure points and increase routing density, strengthening vertical integration and raising switching costs for customers building scalable quantum hardware stacks.
Enterprise Customer ValidationA purchase order from a U.S. Fortune 500 multinational provides enterprise validation and a reference customer for the AME platform. Such tier‑1 engagements support repeatable commercial sales, help scale manufacturing credentials, and improve the firm's go‑to‑market credibility over multiple quarters.
Bears Say
Persistent Cash BurnSustained negative operating and free cash flow implies the business relies on external financing to sustain operations. Continued cash burn constrains investment in R&D and commercialization, forces dilution or debt raises, and creates execution risk if capital markets access tightens over the next several quarters.
Minimal Revenue And Negative MarginsVery low reported revenue and negative gross profit show the company has not yet established positive unit economics or operating leverage. Inconsistent top‑line trends reduce forecastability and mean sizable scaling and margin improvement are required before the business can sustainably fund operations from internal cash generation.
Eroding Equity / Going‑concern FlagsMaterial declines in equity and auditor‑flagged going‑concern considerations indicate the balance sheet is being eroded by recurring losses. Even with debt relatively moderate, shrinking equity undermines financial flexibility and increases refinancing and covenant risk as the company pursues commercialization over the medium term.
QTREX Quantum Ltd News
QTEX FAQ
What was QTREX Quantum Ltd’s price range in the past 12 months?
QTREX Quantum Ltd lowest stock price was $0.28 and its highest was $3.85 in the past 12 months.
What is QTREX Quantum Ltd’s market cap?
QTREX Quantum Ltd’s market cap is $70.16M.
When is QTREX Quantum Ltd’s upcoming earnings report date?
QTREX Quantum Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 26 days.
How were QTREX Quantum Ltd’s earnings last quarter?
QTREX Quantum Ltd released its earnings results on Mar 26, 2026. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.2 by -$0.01.
Is QTREX Quantum Ltd overvalued?
According to Wall Street analysts QTREX Quantum Ltd’s price is currently Overvalued.
Does QTREX Quantum Ltd pay dividends?
QTREX Quantum Ltd does not currently pay dividends.
What is QTREX Quantum Ltd’s EPS estimate?
QTREX Quantum Ltd’s EPS estimate is -0.03.
How many shares outstanding does QTREX Quantum Ltd have?
QTREX Quantum Ltd has 43,579,260 shares outstanding.
What happened to QTREX Quantum Ltd’s price movement after its last earnings report?
QTREX Quantum Ltd reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.2. Following the earnings report the stock price went down -23.092%.
Which hedge fund is a major shareholder of QTREX Quantum Ltd?
Currently, no hedge funds are holding shares in QTEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
QTREX Quantum Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 18.7%
Last 30 Days ▲ 18.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-20.28%
12-Months-Change
Fundamentals
Return on Equity
-278.14%
Trailing 12-Months
Asset Growth
-33.82%
Trailing 12-Months
Company Description
QTREX Quantum Ltd
QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.
Technical Analysis
Ownership Overview
6.84% Insiders
<0.01% Mutual Funds
14.08% Other Institutional Investors
78.99% Public Companies and Individual Investors
Options Prices
Currently, No data available
---